Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Humbert

Showing results (411-420 of 958) with videos related to

Pageof 96
Sort By:
Respiratory Medicine and Research|October 9, 2025
Pulmonary arterial stiffness as the main correlate of effective arterial elastance in pre- and post-capillary pulmonary hypertensionDenis Chemla, Antoine Beurnier, Christian Gerges, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|October 6, 2020
Guidance production before evidence generation for critical issues: the example of COVID-19Nicolas Roche, Thomy Tonia, Andrew Bush, et al.
Revue Medicale De Liege|February 17, 2023
[Advances in pulmonary hypertension diagnosis and risk stratification]Quentin Maloir, Hélène Petitjean, Gilles Parzibut, et al.
Expert Review of Respiratory Medicine|August 14, 2023
Diagnosis and management of pulmonary veno-occlusive diseaseSabina Solinas, Athénaïs Boucly, Antoine Beurnier, et al.
American Journal of Respiratory and Critical Care Medicine|May 11, 2018
Pulmonary Vascular Involvement in Chronic Obstructive Pulmonary Disease. Is There a Pulmonary Vascular Phenotype?Gabor Kovacs, Alvar Agusti, Joan Albert Barberà, et al.
The European Respiratory Journal|August 25, 2022
ERS scientific awards: striving for inclusivityMaeve Tsu, Céline Genton, Sejal Saglani, et al.
The Journal of Clinical Investigation|June 15, 2011
Inhibition of MRP4 prevents and reverses pulmonary hypertension in miceYannis Hara, Yassine Sassi, Christelle Guibert, et al.
Journal of the American College of Cardiology|June 15, 2004
Pathologic assessment of vasculopathies in pulmonary hypertensionGiuseppe G Pietra, Frederique Capron, Susan Stewart, et al.
Advances in Therapy|September 22, 2009
Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertensionDavid Montani, Marie-Camille Chaumais, Laurent Savale, et al.
Respiratory Research|June 11, 2010
Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertensionBarbara Girerd, David Montani, Mélanie Eyries, et al.
Pageof 96

Showing results (411-420 of 958) with videos related to

Sort By:
Pageof 96
Respiratory Medicine and Research|October 9, 2025
Pulmonary arterial stiffness as the main correlate of effective arterial elastance in pre- and post-capillary pulmonary hypertensionDenis Chemla, Antoine Beurnier, Christian Gerges, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|October 6, 2020
Guidance production before evidence generation for critical issues: the example of COVID-19Nicolas Roche, Thomy Tonia, Andrew Bush, et al.
Revue Medicale De Liege|February 17, 2023
[Advances in pulmonary hypertension diagnosis and risk stratification]Quentin Maloir, Hélène Petitjean, Gilles Parzibut, et al.
Expert Review of Respiratory Medicine|August 14, 2023
Diagnosis and management of pulmonary veno-occlusive diseaseSabina Solinas, Athénaïs Boucly, Antoine Beurnier, et al.
American Journal of Respiratory and Critical Care Medicine|May 11, 2018
Pulmonary Vascular Involvement in Chronic Obstructive Pulmonary Disease. Is There a Pulmonary Vascular Phenotype?Gabor Kovacs, Alvar Agusti, Joan Albert Barberà, et al.
The European Respiratory Journal|August 25, 2022
ERS scientific awards: striving for inclusivityMaeve Tsu, Céline Genton, Sejal Saglani, et al.
The Journal of Clinical Investigation|June 15, 2011
Inhibition of MRP4 prevents and reverses pulmonary hypertension in miceYannis Hara, Yassine Sassi, Christelle Guibert, et al.
Journal of the American College of Cardiology|June 15, 2004
Pathologic assessment of vasculopathies in pulmonary hypertensionGiuseppe G Pietra, Frederique Capron, Susan Stewart, et al.
Advances in Therapy|September 22, 2009
Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertensionDavid Montani, Marie-Camille Chaumais, Laurent Savale, et al.
Respiratory Research|June 11, 2010
Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertensionBarbara Girerd, David Montani, Mélanie Eyries, et al.
Pageof 96